Form 4: Integra LifeSciences Executive Mosebrook Reports Stock Disposals
SEC Form 4 Filing
Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences, reports the disposal of common stock to cover tax obligations.
Summary
- On March 10, 2024, Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences Holdings Corp, disposed of 110 and 166 shares of common stock.
- The disposals were executed at a price of $36.73 per share.
- These transactions were related to covering tax obligations.
- Following the reported transactions, Mosebrook beneficially owns 23,990 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock disposals for tax purposes, a routine activity.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be scrutinized by investors for insights into management's perspective on the company's valuation and future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/10/2024 | Date of stock disposal transactions |
| 03/12/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.